Skip to Content Facebook Feature Image

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine

Business

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine
Business

Business

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine

2025-08-08 19:51 Last Updated At:20:15

  • 78 students embark on their journey to become doctors at Duke-NUS Medical School's 19th White Coat Ceremony
  • 46 individuals have made the shift from other careers into medicine, including a lawyer with experience as a yoga coach, a software engineer and professionals from diverse paths, underscoring Duke-NUS' distinct positioning as Singapore's only graduate-entry medical school
  • For the first time, twin sisters enter the MD programme together
  • SINGAPORE, Aug. 8, 2025 /PRNewswire/ -- A new chapter in Singapore's healthcare story began today as 78 aspiring doctors from Duke-NUS Medical School's 19th Doctor of Medicine (MD) cohort donned their white coats and recited the Hippocratic Oath, committing themselves to a future of medical excellence, professionalism and a lifelong service of healing.

    Duke-NUS' Class of 2029 reflects the School's bold and purposeful cultivation of medical talent—by welcoming individuals from a wide spectrum of academic and professional backgrounds.

    This year's students range in age from 22 to 33 and include 46 early-to-mid-career professionals who have switched paths to pursue medicine. Forming the School's largest batch of career-pivoting individuals, they bring with them rich perspectives from fields such as law, software engineering and economics. Also represented are fresh graduates from universities worldwide, as well as seven students admitted through Duke-NUS' conditional pathways in partnership with Singapore's top universities.

    Professor Thomas Coffman, Dean of Duke-NUS, said:

    "Duke-NUS was founded to reimagine how medical talent is developed in Singapore. By welcoming students with many academic backgrounds and life experiences, we bring together diverse minds united by a shared purpose—to serve, to heal and to improve health for generations to come. The White Coat Ceremony reflects our shared commitment for our students to become competent and compassionate doctors who may also contribute to medicine as scientists, educators, policy makers, innovators and future healthcare leaders."

    Along with their undergraduate degrees in a variety of fields, six members of the Class of 2029 hold Master's degrees and one has attained a PhD prior to joining the programme.  

    Among the incoming students is Ms Seah Xue Er, Cheryl, 33, a former senior counsel with J. P. Morgan and a private legal practitioner with a decade of experience in law.

    Ms Seah, who has also taught yoga part-time, believes in competency and in being compassionate when caring for her patients.

    "I want to be a doctor who is hands-on, passionate and relentless in advocating for the best outcome for every patient. I would be someone who perseveres in the duty I have undertaken to provide the best care, treatment and recovery solution for them," she said.

    Another student, Ms Tania Chattopadhyay, 30, left a career in software engineering to pursue medicine—a dream she had wanted to fulfil since being inspired by her father's battle with a heart disorder.  

    Now a mother, she is committed to engineering preventive health solutions in cardiovascular and metabolomic disorders treatment.

    "I believe many conditions can be detected early or even prevented altogether with the right tools, education and systems in place. I want to work on solutions that empower patients to take charge of their health and make care more proactive and effective," she said.

    This intake also includes the School's first pair of twin sisters, Ms Shruthi Kumar and Ms Swathi Kumar, 23, who studied psychology and engineering respectively and share a passion for healing.

     "Taking the next step into medicine together feels incredibly special—not just as a personal milestone but as a shared dream we've nurtured side by side," said Ms Shruthi Kumar, with Ms Swathi Kumar adding: "We've always challenged and supported each other, and now, we're excited to approach learning with different viewpoints and to bring our different strengths to medicine, together."

    Mr Tang Zheng Yang Tony, 24, an English Literature graduate who joined Duke-NUS via a conditional admissions pathway from Yale-NUS College, believes that medicine and literature are "two sides of the same coin" that illuminate the complexities of human life. He hopes to draw from the empathy and introspection instilled in him by his humanities training to offer holistic care as a clinician.

    "I have been blessed with many knowledgeable professors and a wealth of reading material that enliven me not just in an aesthetic sense, but also philosophically and spiritually, forming an important 'human' foundation for the medical profession," said Mr Tang, a recipient of the Duke-NUS Dean's Scholarship.

    The Class of 2029 includes 57 Singaporeans, four permanent residents and 17 international students from countries including China, the United States, the Philippines and India. All students will also undergo most of their clinical training at SingHealth institutions and graduate with an MD degree jointly awarded by Duke University and the National University of Singapore.

    Duke-NUS is the only graduate-entry medical school in Singapore. Its MD curriculum—rooted in research and team-based learning—caters to students who bring maturity, purpose and diverse experiences to medicine.

    About Duke-NUS Medical School
    Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.   

    For more information, please visit www.duke-nus.edu.sg 

SINGAPORE, Aug. 8, 2025 /PRNewswire/ -- A new chapter in Singapore's healthcare story began today as 78 aspiring doctors from Duke-NUS Medical School's 19th Doctor of Medicine (MD) cohort donned their white coats and recited the Hippocratic Oath, committing themselves to a future of medical excellence, professionalism and a lifelong service of healing.

Duke-NUS' Class of 2029 reflects the School's bold and purposeful cultivation of medical talent—by welcoming individuals from a wide spectrum of academic and professional backgrounds.

This year's students range in age from 22 to 33 and include 46 early-to-mid-career professionals who have switched paths to pursue medicine. Forming the School's largest batch of career-pivoting individuals, they bring with them rich perspectives from fields such as law, software engineering and economics. Also represented are fresh graduates from universities worldwide, as well as seven students admitted through Duke-NUS' conditional pathways in partnership with Singapore's top universities.

Professor Thomas Coffman, Dean of Duke-NUS, said:

"Duke-NUS was founded to reimagine how medical talent is developed in Singapore. By welcoming students with many academic backgrounds and life experiences, we bring together diverse minds united by a shared purpose—to serve, to heal and to improve health for generations to come. The White Coat Ceremony reflects our shared commitment for our students to become competent and compassionate doctors who may also contribute to medicine as scientists, educators, policy makers, innovators and future healthcare leaders."

Along with their undergraduate degrees in a variety of fields, six members of the Class of 2029 hold Master's degrees and one has attained a PhD prior to joining the programme.  

Among the incoming students is Ms Seah Xue Er, Cheryl, 33, a former senior counsel with J. P. Morgan and a private legal practitioner with a decade of experience in law.

Ms Seah, who has also taught yoga part-time, believes in competency and in being compassionate when caring for her patients.

"I want to be a doctor who is hands-on, passionate and relentless in advocating for the best outcome for every patient. I would be someone who perseveres in the duty I have undertaken to provide the best care, treatment and recovery solution for them," she said.

Another student, Ms Tania Chattopadhyay, 30, left a career in software engineering to pursue medicine—a dream she had wanted to fulfil since being inspired by her father's battle with a heart disorder.  

Now a mother, she is committed to engineering preventive health solutions in cardiovascular and metabolomic disorders treatment.

"I believe many conditions can be detected early or even prevented altogether with the right tools, education and systems in place. I want to work on solutions that empower patients to take charge of their health and make care more proactive and effective," she said.

This intake also includes the School's first pair of twin sisters, Ms Shruthi Kumar and Ms Swathi Kumar, 23, who studied psychology and engineering respectively and share a passion for healing.

 "Taking the next step into medicine together feels incredibly special—not just as a personal milestone but as a shared dream we've nurtured side by side," said Ms Shruthi Kumar, with Ms Swathi Kumar adding: "We've always challenged and supported each other, and now, we're excited to approach learning with different viewpoints and to bring our different strengths to medicine, together."

Mr Tang Zheng Yang Tony, 24, an English Literature graduate who joined Duke-NUS via a conditional admissions pathway from Yale-NUS College, believes that medicine and literature are "two sides of the same coin" that illuminate the complexities of human life. He hopes to draw from the empathy and introspection instilled in him by his humanities training to offer holistic care as a clinician.

"I have been blessed with many knowledgeable professors and a wealth of reading material that enliven me not just in an aesthetic sense, but also philosophically and spiritually, forming an important 'human' foundation for the medical profession," said Mr Tang, a recipient of the Duke-NUS Dean's Scholarship.

The Class of 2029 includes 57 Singaporeans, four permanent residents and 17 international students from countries including China, the United States, the Philippines and India. All students will also undergo most of their clinical training at SingHealth institutions and graduate with an MD degree jointly awarded by Duke University and the National University of Singapore.

Duke-NUS is the only graduate-entry medical school in Singapore. Its MD curriculum—rooted in research and team-based learning—caters to students who bring maturity, purpose and diverse experiences to medicine.

About Duke-NUS Medical School
Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.   

For more information, please visit www.duke-nus.edu.sg 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine

SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Coda, a global leader in digital content monetization, today announced that it is integrating Unity's In‑App Purchasing (IAP) SDK with Coda's global web store platforms. This collaboration offers developers a single place to manage and optimize their entire digital catalog across mobile, web, and PC - directly through Unity's existing IAP workflow. 

With just a few lines of code, developers can launch secure, branded web stores powered by Coda - offering players more ways to purchase securely while improving their margins.

The integration is powered by Coda's Merchant of Record (MoR) solution, which is already trusted by leading publishers and fast-growing studios worldwide. As the legal seller in each market, Coda manages payments, fraud prevention, tax remittance, invoicing, and compliance across more than 70 markets and over 400 payment methods. This gives developers more time to focus on the game and the player experience.

"As the games industry moves beyond closed ecosystems, developers of every size want more flexibility and control over how they grow," said Shane Happach, CEO of Coda. "Our integration with Unity's IAP SDK gives creators more choice in how they launch and operate their own stores, wherever their players are, minus the complexity of managing global payments or compliance. This reflects Coda's commitment to democratizing game development and helping every studio, large or small, succeed on their own terms."

As web-based purchasing becomes a more practical part of developers' business mix, interest in direct-to-consumer web stores continues to grow. Today, these channels already account for roughly 26% of mobile gaming revenue in East and Southeast Asia, according to research from Niko Partners and Coda.

First-party web stores give developers greater control over pricing, promotions, and player communication, but introduce operational complexity across payments, compliance, fraud, and support. Coda removes these barriers with a scalable payments and risk platform, integrated directly into Unity's workflow.

Coda's integration with Unity's IAP sets a new D2C standard by bringing out-of-app monetization into developers' existing workflows, removing operational complexity, and making it easier to run web stores at a global scale.

Learn more at coda.co.

About Coda

Coda is a global leader in digital content monetization and distribution. We're trusted by 300+ publishers—including Activision, Electronic Arts, and Riot Games—to grow their audiences and revenue worldwide. Our out-of-app solutions include Custom Commerce, a fully customizable web store; Codapay, which enables seamless direct payments through a single API integration on publishers' websites; Codashop, the go-to marketplace for millions of gamers to purchase in-game content; and Distribution, which extends content reach through a network of trusted commerce partners. Founded in 2011, Coda is headquartered in Singapore with a team of 550+ Codans around the globe. Coda recently acquired Recharge, Europe's leading prepaid payments platform.  Coda is backed by Apis Partners, Insight Partners, and Smash Capital, and has been named an APAC High Growth Company (2023) by Financial Times, one of Granite Asia's NextGenTech 30 (2024), a payments leader on Fortune's Fintech Innovation Asia list (2024), and listed among The Straits Times Fastest Growing Fintechs (2024). For more on Coda, visit coda.co.

Press Contacts
Coda:
Liz Adam — VP, Corporate Affairs
elizah.adam@coda.co

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Coda and Unity to enable out-of-app monetization for game developers globally

Coda and Unity to enable out-of-app monetization for game developers globally

Recommended Articles